Diversified Trust’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,642
Closed -$527K 949
2024
Q1
$527K Sell
7,642
-5,325
-41% -$359K 0.02% 495
2023
Q4
$807K Buy
12,967
+525
+4% +$29.4K 0.03% 353
2023
Q3
$698K Buy
12,442
+1,625
+15% +$91.4K 0.03% 349
2023
Q2
$546K Buy
10,817
+2,900
+37% +$154K 0.02% 437
2023
Q1
$432K Buy
7,917
+1,532
+24% +$89.5K 0.02% 514
2022
Q4
$399K Buy
6,385
+1,023
+19% +$67.9K 0.02% 488
2022
Q3
$378K Sell
5,362
-1,275
-19% -$87.9K 0.02% 476
2022
Q2
$376K Buy
6,637
+1,015
+18% +$55.6K 0.02% 495
2022
Q1
$352K Buy
5,622
+2,035
+57% +$110K 0.01% 564
2021
Q4
$201K Buy
+3,587
New +$219K 0.01% 776

Other funds holding AXNX

Diversified Trust's AXNX Position: Q2 2024 in Review

Diversified Trust sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 7,642 shares — an estimated $527K sold.

Diversified Trust first reported a position in AXNX in Q4 2021 and held it in 10 quarters. The position peaked at $807K in Q4 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Diversified Trust reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Diversified Trust sold 7,642 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $527K.
  • Diversified Trust first reported a position in Axonics, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Diversified Trust's Axonics, Inc. Common Stock position peaked at $807K in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Diversified Trust's 13F filing for Q2 2024, filed 16 Jul 2024.